Trexquant Investment’s Impax Laboratories, Inc. IPXL Stock Holding History

Trexquant Investment’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-49,425	Closed	-$796K	–	1179
2017 Q2	$796K	Sell	49,425 -13,651	-22%	-$202K	0.22%	117
2017 Q1	$798K	Buy	+63,076	New	+$762K	0.1%	351
2016 Q3	–	Sell	-32,300	Closed	-$931K	–	1156
2016 Q2	$931K	Buy	32,300 +24,366	+307%	+$794K	0.12%	258
2016 Q1	$254K	Sell	7,934 -2,866	-27%	-$101K	0.03%	785
2015 Q4	$462K	Buy	+10,800	New	+$431K	0.04%	709
2015 Q2	–	Sell	-32,910	Closed	-$1.54M	–	1383
2015 Q1	$1.54M	Buy	32,910 +22,210	+208%	+$884K	0.16%	199
2014 Q4	$338K	Buy	+10,700	New	+$313K	0.06%	643

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Trexquant Investment's IPXL Position: Q3 2017 in Review

Trexquant Investment sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 49,425 shares — an estimated $796K sold.

Trexquant Investment first reported a position in IPXL in Q4 2014 and held it in 7 quarters. The position peaked at $1.54M in Q1 2015. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.

Trexquant Investment reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
Trexquant Investment sold 49,425 Impax Laboratories, Inc. shares in Q3 2017, an estimated $796K.
Trexquant Investment first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 7 quarters.
Trexquant Investment's Impax Laboratories, Inc. position peaked at $1.54M in Q1 2015.
189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.

Based on Trexquant Investment's 13F filing for Q3 2017, filed 9 Nov 2017.